Cash Flow Statement (Annual)
ENUM / Enumeral Biomedical Holdings, Inc. Cash Flow Statement shows changes in cash positions over time. Cash Flow Statement data includes Cash from Operating Activities (CFOP), Cash from Investing Activities, and Cash from Financing Activities.
All numbers are times 1,000 except per share units.
Peers - Pharmaceutical Preparations (2834)
ANTB / AntriaBio, Inc.
AOLS / Aeolus Pharmaceuticals, Inc.
AXIM / Axim Biotechnologies, Inc.
BIVI / BioVie, Inc.
BSPM / Biostar Pharmaceuticals, Inc.
EMIS / Emisphere Technologies, Inc.
ENDV / Endonovo Therapeutics, Inc.
FTCY / Global Future City Holding Inc.
HSTC / HST Global, Inc.
MRNA / Marina Biotech, Inc.
NNAB / NanoAntibiotics, Inc.
PPCB / Propanc Biopharma, Inc.
PPCH / Propanc Health Group Corp.
PRTT / Protect Pharmaceutical Corp
RGRX / RegeneRx Biopharmaceuticals, Inc.
SGBI / Sangui BioTech International, Inc.
SGTH / Signpath Pharma, Inc.
SKVI / Skinvisible, Inc.
as of ET